Nothing Special   »   [go: up one dir, main page]

Hruby et al., 1991 - Google Patents

Topographically designed analogs of [cyclic][D-Pen2, D-Pen5] enkephalin

Hruby et al., 1991

Document ID
7570760940937436380
Author
Hruby V
Toth G
Gehrig C
Kao L
Knapp R
Lui G
Yamamura H
Kramer T
Davis P
Burks T
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Introduction There is now overwhelming evidence from pharmacological considerations2" 4 and fromstructure-activity studies5 that the endogenous opioid peptides methionine enkephalin, leucine enkephalin, and dynorphin interact with several subtypes of opioid …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Similar Documents

Publication Publication Date Title
Hruby et al. Topographically designed analogs of [cyclic][D-Pen2, D-Pen5] enkephalin
EP0843726B1 (en) Opioid antagonists and methods of their use
Toth et al. Ring substituted and other conformationally constrained tyrosine analogs of [cyclic][D-Pen2, D-Pen5] enkephalin with. delta.-opioid receptor selectivity
Mosberg et al. Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivity
US5837809A (en) Mammalian opioid receptor ligand and uses
DE69637430T2 (en) NEW OPIOID PEPTIDE, SELECTIVE TO KAPPA RECEPTOR
RU2223967C2 (en) Inhibitors of viia factor
Mosberg et al. Development of a model for the. delta. opioid receptor pharmacophore. 2. conformationally restricted Phe3 replacements in the cyclic. delta. receptor selective tetrapeptide Tyr-c [D-Cys-Phe-D-Pen] OH (JOM-13)
US4518711A (en) Conformationally constrained cyclic enkephalin analogs with delta receptor specificity
JP2002508767A (en) Cyclic agonists and antagonists of C5a receptor and G protein-coupled receptor
US5780589A (en) Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
JPH06501950A (en) Cyclic peptides, their preparation and their use as pharmacological compositions
Haskell-Luevano et al. Topographical modification of melanotropin peptide analogs with. beta.-methyltryptophan isomers at position 9 leads to differential potencies and prolonged biological activities
Salvadori et al. Phe3-substituted analogs of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by. delta. opioid receptors
WO1989007609A1 (en) Homoarginine-based peptides as platelet aggregation inhibitors
US20010010919A1 (en) Opioid antagonists and methods of their use
EP0374940A2 (en) Polypeptides isolated from the venom of the spider hololena curta
EP0486520B1 (en) Dynorphin analogs specific for kappa opioid receptors
Gairin et al. Synthesis and biological activities of dynorphin A analogues with opioid antagonist properties
Misicka et al. Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity
Portoghese et al. Hybrid bivalent ligands with opiate and enkephalin pharmacophores
Heyl et al. Substitution on the Phe3 aromatic ring in cyclic. delta. opioid receptor-selective dermorphin/deltorphin tetrapeptide analogs: electronic and lipophilic requirements for receptor affinity
US5326751A (en) Enkephalin analogs
Kyle Structure-based drug design: progress toward the discovery of the elusive bradykinin receptor antagonists
Olma et al. The biological consequences of replacing hydrophobic amino acids in deltorphin I with amphiphilic α‐hydroxymethylamino acids